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Abstract 
Rational: Myelin loss is a characteristic feature of both ischemic white matter disease and its associated 
vascular dementia, and is a hallmark of chronic cerebral hypoperfusion due to carotid artery stenosis. Yet the 
cellular mechanisms involved in ischemic dysmyelination are not well-understood, and no effective treatment 
has emerged to prevent or slow hypoperfusion-related demyelination. In a study employing the bilateral 
common carotid artery stenosis (BCAS) mouse model, we found reduced cerebral blood flow velocity and 
arteriolar pulsatility, and confirmed that prolonged BCAS provoked myelin disruption. These pathological 
features were associated with marked cognitive decline, in the absence of evident damage to axons.  
Methods: To assess the role of astroglial communication in BCAS-associated demyelination, we investigated 
the effect of deleting or inhibiting connexin 43 (Cx43), a constituent of astroglial gap junctions and 
hemichannels.  
Results: Genetic deletion and pharmacological inhibition of gap junctions both protected myelin integrity and 
rescued cognitive decline in the BCAS-treated mice. Gap junction inhibition also suppressed the transient 
increase in extracellular glutamate observed in the callosal white matter of wild-type mice exposed to BCAS.  
Conclusion: These findings suggest that astrocytic Cx43 may be a viable target for attenuating the 
demyelination and cognitive decline associated with chronic cerebral hypoperfusion. 
Key words: connexin 43; myelin injury; ischemic white matter disease; astrocyte 
Introduction 
Chronic cerebral hypoperfusion arising from 
carotid artery stenosis is associated with disturbed 
cerebral hemodynamics and cognitive decline [1, 2]. 
Patients experiencing carotid artery stenosis often 
present with white matter injury and progressive 
cognitive impairment, even in the absence of overt 
symptoms or focal neurological deficits [3, 4].  
Little attention has been paid to elucidating the 
temporal sequence of events leading to ischemic 
injury in white matter. Most preclinical studies have 
focused on hypoxic-ischemic injury to the grey 
matter, and a large body of literature has supported 
the concept that glutamate excitotoxicity is a key 
mediator of ischemic injury in grey matter [5, 6]. 
Although axons largely lack glutamate receptors [7, 
8], oligodendrocytes are highly sensitive to 
over-activation of AMPA/kainate receptors [9, 10]. 
Moreover, cellular stress is linked to an increase in the 
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number of open astrocytic Cx43 hemichannels, which 
release glutamate and ATP, and which have been 
shown to promote inflammation following ischemic 
insult via their activation of local astroglial and 
microglial cytokine release [11-13]. In a feed-forward 
fashion, these events may then increase the 
vulnerability of oligodendrocytes to glutamate 
excitotoxicity [14, 15]. 
Given this background, we asked whether 
chronic cerebral ischemia might preferentially target 
the central white matter to provoke glial loss and 
myelin disruption, and if so, whether that process 
might be attenuated by interfering with glial syncytial 
communication via gap junctions. To this end, we 
assessed the effects on the central white matter of 
bilateral common carotid artery stenosis (BCAS), 
using a murine model of BCAS that yields a white 
matter injury resembling that of chronic cerebral 
hypoperfusion in humans [16-19]. In so doing, we 
drew upon prior reports that white matter is affected 
in the BCAS hypoperfusion model [20], with 
disruption of myelin and nodes of Ranvier in the 
absence of overt axonal damage [16]. Using a 
combination of 2-photon imaging of blood flow, 
magnetic resonance imaging of myelin, and 
quantitative light and electron microscopy, we report 
herein that myelin loss precedes axonal injury in 
BCAS, and importantly, that the suppression of 
astrocytic Cx43 protects against deficits in myelin 
integrity and cognition otherwise resulting from 
chronic cerebral hypoperfusion. 
Methods 
Animals  
All experiments were performed according to 
the guidelines of the Institutional Animal Care and 
Use Committee at Tongji Medical College, Huazhong 
University of Science and Technology. Male C57Bl/6 
mice (age, 10–12 weeks; weight, 22–27 g) of SPF grade 
were obtained from Hunan SJA Laboratory Animal 
Co. Ltd., Hunan, China. Mice were housed in groups 
of 2-4 mice per cage under standard housing 
conditions with a 12-h/12-h dark-light cycle and 
provision of food and water ad libitum.  
Astroglial Cx43-deficient mice  
To generate a mouse line in which the gene 
encoding Cx43 was deleted in astrocytes only, we 
followed the procedure as described in a previous 
report [21]. We crossed female GFAP-Cre mice with 
floxed males, since Cre expression was in the male 
germline. In brief, female mGFAP-Cre transgenic 
mice (purchased from Jackson laboratory, line73.12, 
stock Number 012886) were crossbred with male 
Cx43fl/fl mice (purchased from Jackson laboratory, 
stock Number 008039). Then, the female F1 generation 
(GFAP-Cre+ Cx43fl/fl) were crossbred with male 
Cx43fl/fl mice to obtain the F2 generation: 
astroglial-specific Cx43-del mice (GFAP-Cre+ Cx43fl/fl) 
and their normal littermates (Cx43fl/fl) (Figure S1A). 
Rosa-LacZ reporter (Rosa) mice (kindly given by Prof. 
Shumin Duan) were crossbred with the mGFAP-Cre 
transgenic mice. Before performing further 
experiments, we confirmed Cre-recombinase activity 
in the brain of mGFAP-Cre mice [22] by gain of lacZ 
activity, and identified the genotypes of individual F2 
mice by PCR (Figure S1B-D). Astroglial 
Cx43-deficiency was further confirmed by 
immunohistochemistry (Figure S1E-F). 
Experimental design 
All the experimental groups were randomized 
and all outcome analysis was carried out by 
independent investigators blinded to the treatment 
conditions and mouse types. Randomization was 
performed before the surgical procedure (BCAS or 
Sham-operation, Carbenoxolone (CBX)/Meclo-
fenamic Acid (MFA), Gap19/Gap26 administration or 
Vehicle) using the random number generator in 
Graphpad. From the mean and standard deviation of 
outcomes for each group seen in previous studies [16, 
17, 20] and from our own preliminary experiments, 
we calculated that five animals per group would 
suffice to obtain 80% power at a significance level of 
<0.05 with a 2-sided test. Because BCAS leads to 
consistent WM lesions and low mortality, we used 
5-10 animals per group, since the variance depended 
on the particular outcome being studied. A total of 
732 wild-type male mice, 171 Cx43fl/fl male mice, 12 
GFAP-Cre+ Cx43fl/- male mice, 176 GFAP-Cre+ 
Cx43fl/fl male mice, two Rosa-LacZ mice and two 
GFAP-Cre+ Rosa-LacZ mice were used in the 
experiments. Our decision to use exclusively adult 
male mice was intended to minimize sex and age 
differences as factors in the cerebral ischemic injury. 
Future studies will include female mice. A flow 
diagram illustrates the experimental design of the 
study (Figure S2). 
Surgical procedures 
Mice were anesthetized with a mixture of 
ketamine (0.12 mg/g) and xylazine (0.01 mg/g) in 
0.9% NaCl solution administered intraperitoneally. 
Chronic cerebral hypoperfusion was then induced by 
applying wire microcoils (Sawane Spring Co, 
Shizuoka, Japan) with an internal diameter of 0.18 
mm around both common carotid arteries, as 
previously described [17, 23], to induce chronic 
hypoperfusion instead of complete occlusion. 
Sham-operated animals underwent identical surgical 
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interventions except without application of microcoils 
to the common carotid arteries. 
Carbenoxolone (CBX), Meclofenamic Acid 
(MFA), Gap26 and Gap19 treatment 
ALZET osmotic mini-pumps (Cupertino, CA, 
model 1004; reservoir volume 100 μl, pumping rate 
0.11 μl/h, with continuous application for one month) 
were filled with different concentrations of CBX (0.1, 
0.5, or 2.5 μg/μl, Sigma–Aldrich, USA), MFA (0.1, 1, 
or 10 mM, Sigma–Aldrich, USA), Gap 26 (2.0 μg/μl, 
TOCRIS Bioscience, UK, CAS Number 197250-15-0), 
Gap 19 (2.0 μg/μl, TOCRIS, Bioscience, UK, CAS 
Number 1507930-57-5) or saline vehicle [14, 24-26]. 
The pumps were connected to brain infusion cannula 
(Brain Infusion Kit 3, ALZET, Cupertino, CA) via a 
catheter tube and primed by placement at 37 °C for 24 
h prior to subcutaneous implantation. After creating a 
burr hole, the infusion cannula was directed to the 
right ventricle (anterior-posterior = -0.4 mm, 
medial-lateral = 1.0 mm, and dorsal-ventral = 3.0 mm) 
using the stereotaxic frame, and stabilized on the skull 
with dental cement. The ALZET pump was placed in 
a subcutaneous pocket prepared under the skin of 
back, and the catheter was guided under the skin to 
the exposed skull. The scalp wound was closed with 
suture, and in the same surgical session the mice 
underwent BCAS surgery as described above, 
beginning just at the start of the drug or saline 
delivery via minipump. 
In vivo two photon imaging 
Images of mouse vasculature were acquired 
dynamically by two-photon microscope laser 
scanning as described previously [27, 28]. Mice from 
sham operated and BCAS groups were anesthetized 
intraperitoneally with a mixture of ketamine (0.12 
mg/g) and xylazine (0.01 mg/g) in 0.9% NaCl 
solution and then intubated and ventilated with a 
small animal ventilator (CWE). Blood gasses were 
monitored and body temperature was maintained at 
physiological parameters (~100 breaths/min, tidal 
volume of 0.3–0.4 ml, pO2= 80–150 mmHg, pH 
7.25–7.5, body temperature of 37 °C). For vasculature 
imaging, we injected 0.1 ml of blood–brain barrier 
impermeable Texas Red-conjugated dextran-70 (MW, 
70 kDa; 1% in saline; Invitrogen) to a femoral artery 
just before imaging. A MaiTai laser (Spectra Physics) 
attached to a confocal scanning system (LSM710, Carl 
Zeiss) and an upright microscope (20x/1.0, water 
immersed, WD, 1.8 mm, W-Plan-Apochromat 75 mm, 
DIC slide Senarmont) was used to image the cortex; 
the excitation wavelength was 870 nm.  
To measure vessel diameters, we acquired 3000 
ms X–T line scans orthogonal to the vessel axis in 
penetrating arteries 50–150 μm below the cortical 
surface. The line-scans were collected along the 
centerline of each vessel at a scan rate of 1.6 kHz/line. 
RBC velocity was determined from the slope of the 
line-scan. Planar image stacks (256 by 256 pixels) were 
acquired to establish the vessel diameter. The mean 
(SD) diameters of (N=3) penetrating arteries 
measured per mouse was 10.0 ± 5.1 μm (n=6 mice for 
each group). The vessel wall pulsatility (derived units 
m*ms) was calculated as the absolute value of area 
under the diameter–time plot, integrated about the 
running average over the 3000 ms epoch (Figure 1). 
Immunohistochemistry 
At three days, ten days, one month, or three 
months after surgery, mice were perfused with 20 ml 
of 0.9% heparinized phosphate-buffered saline (PBS) 
and then 20 ml 4 % paraformaldehyde (PFA) while 
deeply anesthetized. After brain removal, coronal 
slices (10 μm thick) were prepared at -20 °C using a 
constant temperature freezing microtome (CM 1900, 
Leica, Germany). The primary antibodies used in this 
study were: myelin-associated glycoprotein (MAG, 
1:100, Santa Cruz Biotechnology), myelin basic 
protein (MBP, 1:100, Millipore), neurofilament-Light 
(NF-L), neurofilament-Medium (NF-M), and 
neurofilament-Heavy (NF-H) (1:1000, Cell Signaling 
Technology), Caspr (1:100, UC Davies NIH 
NeuroMab), panNfasc (kindly provided by Prof. Peter 
Brophy), type Ⅵ sodium channel (Nav1.6, 1:200, 
Millipore), connexin43 (Cx43, 1:200-1:250, Abcam) , 
glial fibrillary acidic protein (GFAP, 1:200, Sigma), 
microtubule-associated protein2 (Map2, 1:200-1:400, 
Abcam), neuronal nuclei (NeuN, 1:200, Chemicon), 
ionized calcium binding adapter molecule 1 (Iba-1, 
1:500, Wako Pure Chemical Industries), macrosialin 
(CD68, 1:200, BIO-RAD), Neurofilament H 
Non-Phosphorylated (SMI32, 1:200, Cell Signaling 
Technology) and glutathione-s-transferase π (GSTπ, 
1:200, Abcam). Secondary antibodies, which included 
FITC, Cy3, AlexaFluor488, and AlexaFluor647, 
purchased from Jackson ImmunoResearch 
Laboratories. Sections were incubated with primary 
antibodies overnight at 4 °C in PBS (pH 7.4), along 
with 0.1% Triton X-100. Images were acquired by 
confocal microscopy (FV1200, Olympus, Japan). 
Confocal settings were kept the same during every 
single immunofluorescence staining experiment. 
Nodes of Ranvier Imaging 
For visualizing the nodes of Ranvier, images 
were acquired with a 100× oil immersion objective. 
Length measurements and co-localization assessment 
were performed using Imaris (Bitplane AG, 
Switzerland) and ImageJ (NIH, USA) software as 
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previously described [16]. 
Sodium channel cluster (Nav1.6) length was 
assessed after one month of hypoperfusion. The 
identity of the nodes of Ranvier was confirmed by 
Caspr/Neurofascin double labeling. All length 
measurements were performed using ImageJ [16]. For 
Caspr and Neurofascin, common epitope labeling 
co-localization analysis [29] was performed using 
Imaris software (Bitplane AG, Switzerland), and 
Pearson coefficients were determined for the 
correlations.  
Luxol fast blue staining and X-gal staining, 
Electron Microscopy, Western Blots and 
Eight-arm radial maze test 
A detailed description of these experimental 
procedures is provided in the online-only Data 
Supplement. The methodology for scoring the 
severity of WM lesions was as previously reported. 
[17, 30] In brief, to gauge the severity of white matter 
lesions, the tissue was graded by two independent 
investigators as follows: normal (grade 0), 
disarrangement of nerve fibers (grade 1), formation of 
marked vacuoles (grade 2), or disappearance of 
myelinated fibers (grade 3). 
Magnetic resonance imaging 
At one month post-surgery, mice were 
re-anesthetized and placed in a magnetic resonance 
imaging (MRI)-compatible holder. Structural MRI 
data were collected using a Bruker 7 T preclinical 
scanner with a 72 mm volume coil and a phased array 
mouse brain coil, as previously described [31]. In 
brief, axial diffusivity (AD), mean diffusivity (MD), 
fractional anisotropy (FA), and radial diffusivity (RD) 
maps were generated using the Bruker software 
PARAVISION 5.0 and processed for region of interest 
(ROI) analysis (Figure S2A). White matter ROIs, 
including corpus callosum, fimbria, internal capsule, 
anterior commissure, and optic tract, were selected 
from within T2-weighted structural volumes by an 
observer blinded to intervention, and then transferred 
onto the parametric maps for measurements. 
Microdialysis 
Cerebral microdialysis was used to determine 
the interstitial concentrations of glutamate, adenosine, 
and lactate in living mice. All experiments were 
performed in non-anesthetized freely moving mice at 
day zero, three days or one month after surgery. 
Microdialysis probes (MD-2211 for probes, MD-2255 
for cannula, BASi, USA) in the white matter 
(anterior-posterior = -1.0 mm, medial-lateral = 1.0 
mm, and dorsal-ventral = 1.8 mm) were continuously 
perfused with artificial cerebrospinal fluid (aCSF) at 
flow-rates of 0.1, 0.5, 1.0, and 1.5 μl/min (BASi 
microdialysis pump, USA). Four dialysate samples (5 
μl) were collected at 30 min intervals to determine the 
baseline concentrations. Perfusion of the probes at 1 
μl/min was maintained two hours before the actual 
sampling to attain the steady-state concentrations of 
the analytes. The prepared samples were stored at -80 
°C for further analysis. 
Chromatography 
The microdialysate samples were analyzed for 
glutamate using a Dionex Ultimate 3000 HPLC 
system as previously described [32]. In brief, the 
calibration standards of glutamate prepared at five 
different concentration levels (0.10, 0.50, 1.0, 5.0, and 
15.0 μM) were derivatized with o-phthalaldehyde in 5 
mM sodium sulfite and detected with colormetric 
detection for the calibration curve generation. The 
calibration curves were constructed by plotting the 
peak areas of compounds (y, nA*min) against their 
concentration (x, μM), and used to calculate by 
interpolation the glutamate concentrations in both 
aCSF and real microdialysate samples from the mouse 
brain. 
The microdialysate samples from white matter 
were run under the same conditions as the standards 
[32]. The intra-day and inter-day variabilities for the 
compounds were assessed by obtaining triplicate 
samples on the same day and on three consecutive 
days, respectively. 
Enzymatic colorimetric assays 
Portions of microdialysate samples were 
analyzed for lactate and adenosine content using 
enzymatic lactate and adenosine assay kits (Biovision, 
Mountainview, CA, USA) according to the 
manufacturers’ guidelines. Fluorescence was 
measured at 590 nm (lactate) and 587 nm (adenosine) 
using a microplate reader (Model 680 Bio-Rad, 
Hercules, CA, USA) at an excitation wavelength of 
535 nm.  
1H NMR analysis 
The dissected white matter samples were 
collected in Eppendorf tubes and frozen by 
immersion in liquid nitrogen as soon as possible post 
mortem. The white matter samples were later 
homogenized in 0.1 M HCl/methanol at room 
temperature using a Qiagen Tissue-Lyzer 
(RetschGmBH, Germany) operating at 20 Hz for 90 s. 
Then the homogenized mixtures were decanted and 
centrifuged three times (16000 g, for 10 min at 4 °C), 
with pooling of the supernatants. The collected liquid 
was lyophilized and dissolved in 540 μl 12.5 mMPi (90 
mM K2HPO4 and 35 mM KH2PO4) and 60 μl D2O for 
1H NMR analysis. 
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The 1H NMR spectra were acquired and data 
analysis performed as previously described [33, 34]. 
In brief, all 1H-NMR spectra were acquired at 298 K on 
a Bruker Avance III 600 MHz NMR spectrometer 
(operating at 600.13 MHz for 1H) equipped with an 
inverse cryogenic probe using a standard 
solvent-suppressed one-dimensional pulse sequence 
(the standard WATERGATE pulse sequence). A total 
of 32 k data points and 64 transients were collected for 
each spectrum with a spectral width of 20 ppm. The 
1H-NMR spectra were analyzed with the NMRSpec 
software [35] for measurement of metabolite 
concentrations. We have successfully used the 
NMRSpec software for metabolomics in several 
previous studies [33].  
Statistical analysis  
Statistical analyses were performed using SPSS 
19.0. All data were expressed as the mean ± SEM 
(except for in vivo two photo imaging mentioned 
above). Data were first tested for normality using the 
Kolmogorov-Smirnov test. Single comparisons to 
control results were made using 2-tailed Student’s 
t-test and multiple comparisons within the same data 
set were analyzed by one-way analysis of variance 
(ANOVA) with Dunnett’s post-hoc test. 
Mann–Whitney U test was used to compare the 
severity of WM lesions between the groups. One-way 
ANOVA with repeated analysis was conducted in the 
eight-arm maze test. Differences were considered 
statistically significant at a P value of <0.05. 
Results 
Hypoperfusion leads to reduced RBC velocity, 
arteriolar pulsatility, and diameter 
Several studies have reported that the white 
matter is particularly vulnerable to chronic 
hypoperfusion [13, 16, 17]. To assess the evolution of 
hypoperfusion-associated white matter pathology, we 
adopted the BCAS model of chronic hypoperfusion, in 
which coils are placed around both common carotid 
arteries permanently (Figure 1A). The RBC velocity 
was evaluated by two photon in vivo imaging with 
line scanning at three days, ten days and one month 
post BCAS (Figure 1B-C). The reduction of RBC 
velocity along arterioles was most striking at three 
days post-BCAS, when there was an approximately 
55% reduction relative to the velocity in sham 
controls. RBC velocity along the arterioles recovered 
gradually, but plateaued at 80% of baseline ten days 
post-BCAS. No statistically significant reduction of 
cerebral RBC velocity was noted at one month 
following BCAS (Figure 1C). We next assessed the 
penetrating arteriole diameter and pulsatility (Figure 
1D). The mean diameter of penetrating arterioles was 
25% lower at three days post-BCAS, but there was no 
discernible reduction at ten days or one month 
post-BCAS (Figure 1E). We also analyzed the rapid 
pulsatile movements of the vascular wall, taking 
advantage of the high temporal resolution of two 
photon imaging in vivo [27, 36]. Pulsatility analysis 
showed a transient initial reduction by as much as 
60%, which had recovered at one month post-surgery 
to levels close to those observed in sham operated 
mice (Figure 1F). Overall, these observations show 
that bilateral common artery stenosis significantly 
reduced arteriole pulsatility and diameter and 
likewise reduced cerebral blood flow for at least ten 
days (Figure 1).  
Chronic hypoperfusion leads to loss of white 
matter integrity 
We next asked if reduced cerebral blood flow 
and penetrating arteriole pulsatility would affect 
myelin integrity. The expression of myelin associated 
glycoprotein (MAG), a marker for myelin-axon 
integrity [37], as well as the expression of myelin basic 
protein (MBP) and the axonal marker neurofilament 
(NF)[38, 39], respectively, were quantified at three 
days, ten days, one month, and three months 
post-injury in the BCAS group using immunochemis-
try and western blots; all results were compared to 
those obtained from the sham-operated group. 
A sharp drop in MAG expression was noted at 
day three, which progressed throughout the three 
months observation period. The MAG expression was 
significantly decreased at one month compared with 
ten days after BCAS, but there was no significant 
change of MAG expression between one and three 
months post-BCAS (Figure 2A-C). In contrast, the 
expression of MBP showed an overall decreasing 
trend and a significant decrease lasting until three 
months post-BCAS. The neurofilament-heavy (NF-H), 
neurofilament-medium (NF-M), neurofilament-light 
(NF-L) all remained stable until three months 
post-BCAS, at which point NF-L displayed significant 
reductions (Figure 2A-E). Thus, compromised 
myelin-axon integrity was already evident by three 
days after hypoperfusion injury, even though the 
myelin still appeared intact, as defined by MBP 
immunofluorescence and western blots analysis. 
Concurrently, the expression of the neurofilament 
proteins NF-H, NF-M, NF-L, comprising a canonical 
set of markers of axonal integrity, exhibited no 
detectable changes. Thus, we confirmed previous 
observations [16] that mice with chronic 
hypoperfusion exhibited a significant disruption of 
myelin-axon integrity at early time-points following 
BCAS, prior to any histological evidence of axonal 
damage. 
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Figure 1. Reduction of blood flow velocity and arteriole pulsatility after BCAS. (A) Schematic of BCAS model. (B) Representative images showed the penetrating 
artery at a depth of 60 μm below cerebral cortex surface in BCAS mice at three days post-surgery. Red blood cell (RBC) velocity was detected by two photon line scanning from 
the penetrating arterioles centerline axis (white line). The streaks within the line scan images represent non-fluorescent RBCs moving across a fluorescent background, where 
δx represents the distance traveled by RBCs during the time interval, δt. The RBC velocity is then calculated from the regression slope as shown in the equation. Scale bar, 2 µm. 
(C) Representative images of RBC movement in penetrating vessels and comparison of RBC velocity along a penetrating arteriole at three days, ten days, and one month post 
BCAS. **p˂0.01 **p˂0.01 versus Sham, one-way ANOVA with Dunnett’s post-hoc test, n=6 mice for each group and sampling of three vessels for each mouse. (D) Cortical 
penetrating arteries were selected and the X–T line scans (white lines) were generated orthogonal to the vessel axis. Vascular pulsatility was then calculated as the absolute value 
of the integral of vascular diameter during a three second recording. The penetrating arteriole diameters and pulsatility were evaluated by two photon imaging at three days, ten 
days, and one month post-BCAS. Scale bar, 20 µm. (E-F) A bar histogram comparison of penetrating arteriole diameters and pulsatility at three days, ten days and one month 
post BCAS compared to sham operated mice *p˂0.05 **p˂0.01 versus Sham, #p˂0.05 ##p˂0.01 versus three days post BCAS, one-way ANOVA with Dunnett’s post-hoc test, 
n=6 mice in each group and sampling of three vessels in each mouse.  
 
To critically extend this observation and assess 
the sequence of injury in the BCAS model of chronic 
hypoperfusion, we next utilized MR diffusion tensor 
imaging (DTI) to measure the integrity of the myelin 
sheath and axonal structures in the medial part of 
corpus callosum (CCm), peripheral part of corpus 
callosum (CCp), anterior commissure (AC), fimbria of 
the hippocampus (F), internal capsule (IC), and optic 
tract (OT) (Figure S3A). We found that the fractional 
anisotropy (FA) decreased in the IC and OT at day 
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three, in CCm at day ten, and in F at one month; these 
FA decreases progressed with hypoperfusion 
post-BCAS, indicating progressive loss of white 
matter integrity (Figure 3A-B, Figure S3C). The radial 
diffusivity (RD) was slightly different between 
groups, and the increase in RD was significant in the 
CCm, F, and IC at one month post-BCAS, 
demonstrating that the disruption of myelin had 
occurred by this time (Figure 3C-D, Figure S3D). The 
FA and RD values also differed at one month 
post-hypoperfusion, consistent with the time course 
of white matter pathology. There was no significant 
change in mean diffusivity (MD) in any region except 
for the OT, where no changes presented until three 
months post-hypoperfusion (Figure S3E), while axial 
diffusivity (AD) remained roughly constant until 
three months in F, IC, and OT (Figure S3F). These data 
suggested that there was no loss to axonal integrity 
until three months post-hypoperfusion. The 
T2-weighted imaging data revealed no overt 
structural changes in any of the mice studied (Figure 
S3B), which was consistent with the histological 
observations. 
 
 
Figure 2. Myelin disruption was observed in chronic hypoperfusion mice. (A) Representative images depicting immunofluorescent labeling of myelin-associated 
glycoprotein (MAG), myelin basic protein (MBP), and neurofilament (NF) in coronal slices from sham-operated mice and bilateral common carotid artery stenosis (BCAS) mice 
at different time points post-surgery (three days, ten days, one month and three months). Scale bar, 100 µm. (B) The expression of MAG, MBP and NF (three major NF subunits 
based upon their molecular mass: lowest (NF-L), the middle (NF-M) and the highest (NF-H)) was determined by western blots at three days, ten days, one month, and three 
months post-BCAS and quantitative analysis of results in (B) was performed (C-E). *p˂0.05, **p˂0.01 versus Sham, #p˂0.05 ##p˂0.01 versus ten days post-BCAS, one-way 
ANOVA with Dunnett’s post-hoc test, n=6 mice for each group. 
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Figure 3. White matter disruption following BCAS detected by MRI and electron microscopy. (A, C) Selected regions of 7.0 Tesla (T) MRI for inspecting the 
integrity of myelin sheath and axonal structures in different regions of white matter (the medial part of corpus callosum (CCm), peripheral part of corpus callosum (CCp), 
anterior commissure (AC), fimbria of hippocampus (F), the internal capsule (IC) and the optic tract (OT)) at different time points (three days, ten days, one month, and three 
months) post BCAS. (B, D) Quantitative analysis of fractional anisotropy (FA) and radial diffusivity (RD) at different time points (three days, ten days, one month and three 
months). Arrowheads indicate vacuoles and delamination, which are classical signs of disruption of myelinated structures. *p˂0.05, **p˂0.01 versus Sham, one-way ANOVA with 
Dunnett’s post-hoc test, n=6 mice for sham and three months, n=5 for three and ten days, and n=7 for one month. (E) Representative electron microscopy images of axons in 
corpus callosum of sham-operated and BCAS mice at three days, ten days, one month and three months post-BCAS. Representative electron microscopy images are from 
sham-operated and BCAS mice at one month post-BCAS. Scale bar, 2 µm. (F) Scatter plot diagram of the g ratios (the inner axonal diameter relative to the total outer diameter) 
and axon diameter was performed at one month post-injury. (G) Quantitative analysis of g ratios at different time points (three days, ten days, one month and three months) post 
injury. **p˂0.01, p>0.05 versus Sham, one-way ANOVA with Dunnett’s post-hoc test, n=200 myelinated axons (40 axons per mouse, 5 mice per group) for each group. 
 
We also detected ultrastructural damage of the 
CCm in the hypoperfused mice, finding vacuoles and 
delamination in BCAS mice from three days 
post-injury and persisting throughout the three 
months observation period, whereas well-defined 
lamellar myelin sheaths remained intact in 
sham-operated mice (Figure 3E). Quantitative 
analysis of g ratios confirmed the ultrastructural 
disruption of myelin first presenting at ten days 
post-hypoperfusion in BCAS mice, while the axons 
remained intact (Figure 3F-G). 
In the next phase we applied luxol fast blue 
(LFB) staining as a highly sensitive marker of myelin 
loss. There was decreased LFB staining in the CCm 
first appearing at three days, and with progression 
thereafter. The caudate-putamen (CPu), AC, IC 
exhibited significant loss in staining at one and three 
months, whereas F displayed a tendency of myelin 
loss, but was not significantly altered. The most severe 
rarefaction of myelin was evident in the CCm (Figure 
4A-B). Consistent with the preservation of axons and 
NF, the density of Map2- and NeuN-immunoreactive 
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neuronal cell bodies remained normal throughout the 
observation period, as previously reported [16] 
(Figure S4C-E). Together, these multiple approaches 
including quantitative immunohistochemistry, 
electron microscopy, and MRI, all indicated that white 
matter injury induced by chronic hypoperfusion 
results in early disruption of the relationship of axons 
with their myelin sheaths, followed by late 
demyelination. These changes were most notable in 
the CCm. In contrast, the number of NeuN- and 
Map2-defined neurons and their axons remained 
intact during the three months observation period. A 
schematic diagram compares the temporo-spatial 
pattern of myelin injury in the BCAS model detected 
by multiple alternative approaches (Figure S5). 
 
 
Figure 4. BCAS-associated white matter disruption was protected by gap junction inhibition. (A) Representative confocal images of coronal sections labeled with 
MBP and MAG from sham-operated and carbenoxolone (CBX) and meclofenamic acid (MFA) treated groups. The severity of white matter lesions was also assessed by Luxol fast 
blue (LFB) staining. Quantitative analysis was performed in (E). **p˂0.01 versus Sham, ##p˂0.01 versus Vehicle, one-way ANOVA with Dunnett’s post-hoc test, n=10 mice per 
group. Scale bars, 300 µm and 50 µm. (B) Expression of MAG and MBP was determined by western blots in mice from sham-operated and vehicle, CBX and MFA treated group. 
(C-D) Quantitative analysis of (B). **p˂0.01 versus Sham, ##p˂0.01 versus Vehicle, one-way ANOVA with Dunnett’s post-hoc test, n=6 mice per group. (F) Representative 
confocal images of coronal sections stained for MBP and MAG from Cx43fl/fl BCAS mice, GFAP-Cre+ Cx43fl/fl (Cx43-/-) mice and sham-operated littermate controls at one month 
post-surgery. Expression of MAG and MBP was determined by western blots (G-I) and severity of white matter lesion was assessed by LFB staining. Quantitative analysis was 
performed in (J). **p˂0.01 versus Sham, ##p˂0.01 versus Cx43fl/fl BCAS mice, one-way ANOVA with Dunnett’s post-hoc test, n=6 mice per group. Scale bars, 300 µm, 50 µm. 
(K) 7 T MRI scan detecting the integrity of myelin sheath and axonal structures in corpus callosum, internal capsule and optic tract in Cx43fl/fl BCAS mice, Cx43-/- BCAS mice and 
sham-operated control at one month post-surgery. (L-M) Quantitative analysis of fractional anisotropy value (FA) and axial diffusivity (RD) value in (K). *p<0.05, **p<0.01 versus 
Cx43fl/fl Sham, #p<0.05, ## p<0.01 versus Cx43fl/fl BCAS mice, one-way ANOVA with Dunnett’s post-hoc test, n=4 for Cx43-/- sham-operated control, n=5 for Cx43fl/fl BCAS 
mice, Cx43-/- BCAS mice and Cx43fl/fl sham-operated control.  
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White matter damage was reduced by gap 
junction inhibition 
We previously showed that pharmacological 
inhibition of gap junctions or deletion of astrocytic 
connexin 43 (Cx43) can ameliorate delayed neuronal 
death in a mouse model of middle cerebral artery 
occlusion [40]. On that basis, we now asked whether 
the white matter impairment in BCAS mice is also 
modulated by Cx43. To this end, we analyzed the 
expression of Cx43 at three days, ten days, one month, 
and three months post-BCAS. We found that Cx43 
expression increased at three days, peaking at one 
month post-BCAS, which was accompanied by 
astrocytic activation, detected as an upregulation of 
GFAP (Figure S6A-C). 
Carbenoxolone (CBX) and meclofenamic acid 
(MFA) are two commonly used inhibitors of gap 
junction proteins [14, 41], including Cx43 [24, 25]. We 
treated BCAS mice by administering increasing 
concentrations of CBX (0.1, 0.5 and 2.5 μg/μl) and 
MFA (0.1, 1 and 10 mM) with an osmotic minipump 
(Figure S6D-E). The minimum effective concentration 
to ameliorate myelin loss was 0.5 μg/μl for CBX and 1 
mM for MFA (Figure S6D-E), which proved sufficient 
to block the BCAS-associated upregulation of Cx43 
and activation of astrocytes (Figure S6F-H). To assess 
potential harmful effects of long time intraventricular 
infusion of the Cx inhibitors to mice, wild-type control 
mice were next treated with CBX (0.5 μg/μl), MFA (1 
mM), or vehicle (saline, same volume) continuously 
for one month (Figure S7). An eight-arm maze test 
was performed on these mice at the end of the one 
month treatment. No difference in performance was 
observed between the three groups, i.e. CBX, MFA, or 
vehicle (Figure S7A). LFB staining revealed no 
structural damage to myelin after intraventricular 
infusion of CBX or MFA for one month (Figure S7C). 
Next, we tested the expression of MAG and MBP in 
CBX-treated and MFA-treated mice at one month 
post-BCAS. The reduction in MAG expression in 
BCAS mice one month post-injury was partly 
reversed by treatment with the connexin inhibitors 
CBX and MFA, suggesting partial pharmacological 
rescue of the insult to myelin sheaths (Figure 4A-D). 
Myelin integrity was preserved by these treatments, 
as assessed by LFB staining (Figure 4A and 4E). Thus, 
two different gap junction blockers substantially 
rescued the late white matter damage caused by 
hypoperfusion (Figure 4A-E). 
To specifically test for a critical role of astrocytic 
Cx43 in white matter damage induced by BCAS, we 
next exposed astrocyte-specific Cx43 conditional 
knockout mice (Figure S1A-F) to BCAS. We first 
compared Cx30 expression in the conditional 
knockout mice and wild-type mice using western 
blots (Figure S8). We saw a minor increase of Cx30 
expression in Cx43 conditional knockout mice 
compare to wild-type, while Cx30 expression did not 
change upon chronic hypoperfusion in the 
conditional knockout mice (Figure S8A-B). The 
expression of Cx43 to western blots of white matter 
did not differ between Cx43fl/fl and wild-type control 
mice (Figure S8C-D). Both the reduction in MAG 
expression and loss of white matter integrity were less 
pronounced at one month post-BCAS in mice with 
deletion of Cx43, as assessed by immunofluorescence, 
western blots and LFB staining (Figure 4F-J). On that 
basis, we next analyzed using structural MRI the 
effect of Cx43 deletion on BCAS-associated loss of 
myelin integrity. The decrease in FA of the white 
matter was significantly lower in mice with deletion 
of Cx43 (Figure 4K and 4L). A similar protective 
change in the RD value was detected in the CCm 
(Figure 4K and 4M), consistent with the attenuation of 
white matter pathology in the Cx43 nulls. Moreover, 
we evaluated the protective effect of genetic ablation 
of Cx43 on oligodendrocytes, finding that the number 
of GSTπ-positive cells was decreased in Cx43fl/fl mice 
at one month post BCAS, whereas GSTπ expression 
was unaffected in Cx43 knockout mice. (Figure S9) We 
also examined the axonal damage was evaluated by 
immunostaining of Neurofilament H 
Non-Phosphorylated (SMI32) at three days, ten days 
and one month post-injury in the BCAS group. 
Elevated expression of SMI32 was evident in BCAS 
mice only at one month post injury, and this increase 
was rescued by either pharmacological blockade by 
treated with Gap26 or Gap19 or genetic ablation of 
Cx43 (Figure S10). 
Thus, using several different complementary 
approaches, we found that the loss of white matter 
integrity following BCAS was reversed by gap 
junction inhibition or astroglial Cx43 deletion. 
Overall, these results point to astrocytic 
communication via Cx43 (channels or hemichannels) 
as a contributor to myelin loss in the setting of BCAS. 
Structural disruption of the nodes of Ranvier 
was retained if BCAS was combined with 
inhibition of gap junctions or deletion of Cx43 
The nodes of Ranvier, which are flanked by 
myelinated axon segments, are important sites for 
action potential propagation based on the clustering 
of voltage-gated sodium channels (Nav1.6). 
Immunohistochemistry for Caspr and panNfasc 
reveals two key proteins that are essential for the 
integrity of the paranodal junction and the nodes of 
Ranvier [42, 43]. 
We first tested whether chronic cerebral 
hypoperfusion would cause damage to paranodal 
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septate-like junctions. A significant reduction in the 
co-localization of Caspr and panNfasc within the 
paranodes was observed at one month 
post-hypoperfusion, suggesting a breakdown in the 
paranodal structure (Figure 5A and 5C). On that basis, 
we next asked whether disruption of paranodal 
structure would result in the breakdown of the nodes 
of Ranvier. We immunostained coronal brain sections 
for Caspr, and also for Nav1.6 (which is usually 
confined to the nodes and is sequestered by Caspr). 
However, in response to hypoperfusion, Nav1.6 
expression extended beyond the territory of Caspr 
immunoreactivity, as shown by the superimposition 
of Nav1.6 and Caspr staining (Figure 5A). In addition, 
we saw a significant increase in the length of the 
Nav1.6-positive clusters in fibres within the corpus 
callosum in BCAS mice at one month 
post-hypoperfusion (Figure 5B and 5D). 
 
 
Figure 5. Disruption of axon-glial interaction was reversed by gap junction blocking. (A) Representative confocal images immunostained for Caspr/panNfasc and 
Caspr/Nav1.6 in response to hypoperfusion in CBX, MFA, and vehicle-treated mice as well as sham-operated controls at one month post-surgery. Scale bar, 10 µm. (B) A higher 
magnification of (A) is shown. (C) Quantitative analysis of the Caspr/panNfasc co-localization. **p˂0.01 versus Sham, #p˂0.05, ##p˂0.01 versus Vehicle, one-way ANOVA with 
Dunnett’s post-hoc test, n=6 mice per group. (D) Summary of the length of Nav1.6 domain in the corpus callosum is shown in the curve. p˂0.001 CBX-, MFA-treated versus 
Vehicle, Vehicle versus Sham, one-way ANOVA with Dunnett’s post-hoc test, n=6 mice for each group and 100 Nav1.6 domains for each mouse. (E) Representative confocal 
images labeled with Caspr/panNfasc and Caspr/Nav1.6 in Cx43fl/fl, Cx43-/- mice and sham-operated controls at one month post BCAS. Scale bar, 10 µm. (F) A higher magnification 
of (E) is shown. (G) Quantitative analysis of Caspr/panNfasc colocalization is shown in histogram. n=6 mice per group. **p˂0.01 versus Sham, #p˂0.05 versus Cx43lox/lox 
(Cx43fl/fl) BCAS mice, one-way ANOVA with Dunnett’s post-hoc test. (H) Summary of the length of the Nav1.6 clusters in the corpus callosum is shown in the curve. p˂0.001 
Cx43fl/fl BCAS mice versus Sham, Cx43-/- BCAS mice versus Cx43fl/fl BCAS mice, one-way ANOVA with Dunnett’s post-hoc test, n=6 mice for each group and 100 Nav1.6 
domains for each mouse. 
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We next tested the protective effects of CBX and 
MFA treatment on the nodes of Ranvier after 
hypoperfusion injury. There was no alteration in 
either the length of Nav1.6 domains or the 
co-localization of pan-Neurofascin with Caspr in 
CCm of mice treated with either Cx43 inhibitor 
(Figure 5A-D). To further investigate the protective 
effect of astrocytic gap junction blockade on myelin 
integrity, we analyzed the length of Nav1.6 channels 
and neurofascin and Caspr localization in the 
astrocyte-specific Cx43 conditional knockout mice. 
There was no evident difference in these markers 
between the GFAP-Cre+ Cx43fl/fl mice and their 
littermates under physiological conditions, whereas 
the length increase in the Nav1.6 channels and 
selective delocalization of neurofascin and Caspr 
immunostaining in CCm in response to 
hypoperfusion injury were both retained by the 
knockout mice (Figure 5E-H). This finding confirmed 
that selective deletion of astrocytic Cx43 rescued the 
damage to myelin caused by hypoperfusionWe also 
assessed whether the ultrastructural damage to 
paranodes was ameliorated by pharmacological 
inhibition of gap junctions. We found that the g ratio 
was significantly decreased in mice treated with CBX 
and MFA (Figure 6A-D). In addition, there was no 
significant change in the g ratio in astrocytic Cx43 
knockout mice following BCAS, further confirming 
the myelin protective effect of gap junction inhibition 
and deletion of Cx43 (Figure 6E-H). 
As a more specific approach to assess the role of 
Cx43 hemichannels in myelin injury in BCAS mice, 
we next administrated the two Cx43 mimetic peptides 
Gap19 and Gap26 separately by intraventricular 
administrated for one month. Prior studies have 
shown that Gap19 and Gap26 each selectively inhibit 
Cx43 hemichannels [14, 26]. We sought to determine if 
Gap19 and Gap26 could attenuate the myelin 
disruption in BCAS mice, based on 
immunofluorescence staining with MAG and MBP. 
Our results indicated that the reduction in MAG 
expression in BCAS mice one month post-injury was 
partly reversed by treatment with Gap19 or Gap26 
(Figure 7A). Using western blots, we found that the 
decrease in MAG and MBP expression in BACS mice 
was attenuated when treated with either Gap19 or 
Gap26 (Figure 7B-D). Also, we saw no structural 
damage to myelin in BACS mice treated with either 
Gap19 or Gap26 when detected by LFB staining 
(Figure 7A, E). Besides, we assessed the effect of Cx43 
deletion on ischemic white matter injury at three 
months post BCAS through LFB staining. Our results 
showed that Cx43 knockout also protected the myelin 
from injury at three months post hypoperfusion 
(Figure S11). Moreover, the g ratio was significantly 
lower in BCAS mice treated with Gap19 or Gap26 
than in vehicle controls, further confirming that the 
ultrastructural damage to paranodes was ameliorated 
by specific pharmacological inhibition of Cx43 (Figure 
7F-I). 
BCAS-associated deficits in working memory 
were reversed by inhibition of astroglial 
connexin43 
We next asked whether pharmacological 
inhibition of gap junctions would attenuate the 
cognitive impairment induced by BCAS [2]. Working 
memory was assessed using an eight-arm maze test. 
The sham-operated mice made a declining number of 
revisiting errors over the training period, while the 
BCAS mice showed impaired working memory, with 
no improvement in revisiting errors (Figure 8A). The 
number of different arm choices in the first eight 
entries (ranging from four for chance performance to 
eight for a perfect performance) is another measure of 
working memory. The BCAS mice performed much 
worse than the sham-operated mice in each successive 
training session (Figure 8B), yet displayed no 
impairment in spatial reference memory (Figure 8C).  
This cognitive decline in BCAS mice was 
reversed by treatment with the gap junction blockers 
MFA, CBX, or the Cx43 inhibitors Gap19 and Gap26, 
an effect apparent at one month post-BCAS. 
Particularly, the MFA-, CBX-, Gap19- and Gap26- 
treated mouse groups all made fewer revisiting errors 
(Figure 8D, 8J) and more distinct arm choices in the 
first eight entries compared to vehicle-treated mice 
(Figure 8E, 8K). Similarly, genetic deletion of 
astrocytic Cx43 ameliorated cognitive function at one 
month post-BCAS. Knockout of astrocytic Cx43 
resulted in fewer revisiting errors (Figure 8G), and a 
greater number of different arm choices in the first 
eight entries compared to their littermate controls 
(Figure 8H). However, we saw no obvious differences 
in spatial reference memory between the groups 
(Figure 8F, 8I and 8L).  
Overall, these results showed that BCAS mice 
displayed impaired working memory. These 
impairments were reversed in mice treated with any 
of four Cx43 blockers, as well as in Cx43 knockout 
mice, indicating a role of Cx43 in both mediating and 
sustaining BCAS-triggered deficits in working 
memory. 
Interstitial glutamate increases were abolished 
by ablating astrocytic connexin 43  
Astrocytes control and promote the homeostatic 
regulation of extracellular glutamate and potassium 
concentrations, as well as that of other neuroactive 
agents [12]. Astrocytic Cx43 can, however, act as a 
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conduit for the release of neurotransmitters, including 
glutamate and ATP in pathological conditions [44, 45]. 
We here used microdialysis to evaluate the effect of 
Cx43 knock-out on the interstitial concentrations of 
glutamate, adenosine and lactate in BCAS mice. We 
saw a >50% increase in extracellular glutamate 
(Figure 9A-C) and a nearly 30% increase in the 
extracellular lactate concentration at three days 
post-hypoperfusion injury, relative to the levels in 
sham-operated mice (Figure 9D). These differences 
subsequently resolved, such that there were no 
remaining significant differences in interstitial 
glutamate or lactate concentrations in BCAS mice 
compared to sham-operated mice at one month 
post-injury. Deletion of astrocytic Cx43 abolished the 
increases in interstitial glutamate and lactate of BCAS 
mice at three days post-hypoperfusion (Figure 9C-D). 
We did not observe any changes in extracellular 
adenosine concentration in either the acute (three 
days) or chronic (one month) phases after BCAS 
injury in Cx43 knockout or control mice (Figure 9E). 
The total brain glutamate concentration was also 
assessed by 1H NMR analysis. The total concentration 
of glutamate in extracts of the corpus callosum was 
significantly increased at three days following 
hypoperfusion, whereas there was no such change in 
Cx43 knockout mice (Figure 9F-G).  
 
 
Figure 6. Ultrastructural myelin injury was attenuated by inhibition of connexin 43. (A) Representative electron microscopy images from brains collected at one 
month post BCAS in CBX, MFA, and vehicle-treated mice, as well as their sham-operated controls. Scale bar, 2.5 µm. (B-D) Quantitative analysis of the g ratios and axon 
diameters was performed. **p˂0.01 versus Sham, ##p˂0.01 versus Vehicle, one-way ANOVA with Dunnett’s post-hoc test, n=200 myelinated axons (40 axons per mouse, five 
mice per group) for each group. (E) Representative electron microscopy images in Cx43fl/fl mice and GFAP-Cre+ Cx43fl/fl (Cx43-/-) mice at one month post BCAS as well as their 
sham-operated controls. Scale bar, 2.5 µm. (F-H) Quantitative analysis of the g ratios and axon diameters was performed. **p˂0.01 versus Sham, ##p˂0.01 versus Cx43fl/fl BCAS 
mice, one-way ANOVA with Dunnett’s post-hoc test, n=200 myelinated axons (40 axons per mouse, five mice per group) for each group.  
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Figure 7. Protection from BCAS-associated white matter disruption by selective inhibition of Cx43 by two mimetic peptides, Gap19 and Gap26. (A) 
Representative confocal images of coronal sections labeled with MBP and MAG from sham-operated and Gap19 or Gap26-treated groups. The severity of white matter lesions 
was also assessed by Luxol fast blue (LFB) staining. Quantitative analysis was performed in (E). **p˂0.01 versus Sham, ##p˂0.01 versus Vehicle, one-way ANOVA with Dunnett’s 
post-hoc test, n=6 mice per group. Scale bars, 300 µm and 50 µm. (B) Expression of MAG and MBP was determined by western blots in mice from sham-operated and vehicle, 
Gap19, and Gap26-treated groups. (C-D) Quantitative analysis of (B). **p˂0.01 versus Sham, ##p˂0.01 versus Vehicle, one-way ANOVA with Dunnett’s post-hoc test, n=6 
mice per group. (F) Representative electron microscopy images from brains collected at one month post BCAS in CBX, MFA and vehicle treated mice as well as their 
sham-operated controls. Scale bar, 2.5 µm. (G-I) Quantitative analysis of the g ratios and axon diameters was performed. **p˂0.01 versus Sham, ##p˂0.01 versus Vehicle, 
one-way ANOVA with Dunnett’s post-hoc test, n=200 myelinated axons (40 axons per mouse, five mice per group) for each group. 
 
Administering the Cx43 mimetics (gap26 and 
gap19) to BCAS mice for only three days lowered the 
extracellular glutamate content, although glutamate 
content was slightly higher than in BCAS mice treated 
for one month. (Figure S12A-C) Administering the 
Cx43 mimetic peptides for three days by osmotic 
minipumps rescued disruption of axon-myelin 
integrity in the CCm (Figure S12D-G). 
Together, these results suggested that the 
contribution of Cx43 to ischemic white matter injury 
involved increased concentrations of total brain and 
extracellular glutamate levels and possibly also lactate 
in the early post-injury phase. 
Microglial activation was attenuated by 
knockout of astroglial connexin43  
Astrocytic Cx43 hemichannels aggravate the 
inflammatory response to injury and cellular stress by 
releasing glutamate and ATP, which subsequently 
activate microglia, triggering the additional release of 
proinflammatory cytokines and thus increasing the 
susceptibility of oligodendrocytes to excitotoxicity 
[14, 15, 46]. We therefore asked whether microglial 
activation post-BCAS was affected by the deletion of 
Cx43. Chronic hypoperfusion triggered a significant 
increase in Iba-1 and CD68 positive microglial cells, 
which peaked at ten days post-BCAS injury. Genetic 
deletion of Cx43 significantly reduced the activation 
of microglial cells(Figure S13A-C). Moreover, 
increased expressions of IL1-β, TNF-α and NOX2 was 
detected in the Cx43-/- BCAS mice as well as the sham 
controls, but their expression was lower in Cx43-/- 
mice compared with Cx43fl/fl mice at one month post 
BCAS, which suggests lower neuroinflammation in 
Cx43-/- mice post hypoperfusion injury. Thus, this 
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observation suggested that the presence of astrocytic 
Cx43 contributed to the activation of microglia and 
additional release of proinflammatory cytokines after 
hypoperfusion injury in mice (Figure S14). 
Discussion 
This study assessed the cellular mechanisms 
involved in white matter involution and degeneration 
in a murine model of chronic brain hypoperfusion. In 
our model of chronic carotid hypoperfusion, we place 
obstructive coils around the common carotid arteries 
to suppress both cerebral blood flow and arterial 
pulsatility, with these effects peaking at three days, 
followed by a slow recovery over the month 
thereafter. Blood flow is reduced in this model of 
chronic hypoperfusion [47, 48], and is linked to a 
progressive atrophy of white matter, in the absence of 
overt pathology in either cortical or subcortical gray 
matter regions [13, 16, 17]. The white matter loss 
suffered by these mice was characterized by early 
oligodendrocytic loss and myelin atrophy, which 
occurred prior to any detectable axonal degeneration. 
 
 
Figure 8. Working memory impairment was improved by inhibition of astroglial Cx43. The working memory of mice from each group was assessed by the 
eight-arm maze test at one month post-injury. One-way ANOVA with repeated analysis. (A-C) At one month post injury the BCAS mice made many more revisiting errors 
(p<0.001) and fewer different arm choices in the first eight entries (p=0.002) compared to the sham-operated mice. No impairment of spatial reference memory was revealed 
for BCAS mice in the eight-arm maze test (p=0.776). n=8 mice for each group. (D-F) There were far fewer revisiting errors in MFA- and CBX-treated groups (p<0.001) and far 
more different arm choices made in the first eight entries (p<0.05) compared to vehicle-treated mice, while no obvious difference of reference memory errors was observed 
(p>0.05). n=9 for Sham, n=10 for Vehicle and MFA- and CBX-treated groups. (G-I) At one month after BCAS, GFAP-Cre+ Cx43fl/fl (Cx43-/-) mice made fewer revisiting errors 
(p<0.001) and more different arm choices in the first eight entries (p=0.002) compared to their littermate controls, while no obvious difference in reference memory errors was 
evident (p>0.05). n=8 mice for each group. (J-L) There were far fewer revisiting errors in the Gap26- and Gap19-treated groups (p<0.01), and far more different arm choices 
made in the first eight entries (p<0.05) comparing to vehicle-treated mice, while no obvious difference of reference memory errors was observed (p>0.05). n=8 mice for each 
group. 
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Remarkably, we noted that deletion of astrocytic 
Cx43, as well as pharmacological blockade of gap 
junctions, substantially protected against this white 
matter injury, and attenuated the loss of myelin 
induced by carotid stenosis. The cognitive 
performance of hypoperfused mice was also better 
preserved in those test animals subjected to genetic 
deletion of Cx43, to gap junction inhibitors, or 
peptides blocking Cx43 hemichannels.  
 
 
Figure 9. Interstitial glutamate levels post-BCAS were normalized by ablation of astroglial connexin43. (A) Representative chromatograms of microdialysis 
results depicting the elution profiles of standard amino acid (AA) solutions and microdialysate samples after derivatization with OPA-sulfite for the detection of glutamate. The 
dashed square inset indicated the profile of the extracellular glutamate concentration. Black curve: standard AA solution (10 µM); Green curve: microdialysate from white matter. 
(B) A higher magnification image of a representative microdialysis chromatogram. The black curve depicts results for Cx43fl/fl mice and the red curve GFAP-Cre+ Cx43fl/fl 
(Cx43-/-) mice. (C-E) The interstitial concentrations of glutamate (C), lactate (D) and adenosine (E) in corpus callosum in Cx43fl/fl and Cx43-/- BCAS mice as well as 
sham-operated controls at three days and one month post-surgery. *p˂0.05 versus Sham, #p˂0.05, ##p˂0.01 versus Cx43fl/fl mice at three days post-BCAS, one-way ANOVA 
with Dunnett’s post-hoc test, n=6 mice for each group. (F) The normalized 1H-NMR spectra of white matter tissue extracts, with the dashed square insets, indicating the 
13C-NMR spectra profile of Glu4 in white matter tissue extracts. This figure was derived from the average values of Glu4 concentration in white matter tissue extract and 
standard error (SE), where SE was calculated based on the standard deviation and the number of replicates. (G) The proton signals connected with the C4 in Glutamate in the 
NMR spectra, which was the same as the dash square in Fig. 9G. The black curve depicts the results for Cx43fl/fl mice and the red curve for GFAP-Cre+ Cx43fl/fl (Cx43-/-) mice. 
The green band shows the range of standard error for Cx43fl/fl mice and the blue band shows the corresponding range for Cx43-/- mice. Glu4: sum of all resonances of Glu labeled 
at the carbon 4 position. p˂0.01 versus Cx43fl/fl mice three days post-BCAS, one-way ANOVA with Dunnett’s post-hoc test, n=8 for Cx43-/- sham-operated mice and Cx43-/- 
mice at three days post BCAS, n=9 for Cx43-/- mice at one month post BCAS, n=7 for all the littermate control groups. 
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Together, these results indicate that chronic 
hypoperfusion primarily targets the white matter glial 
syncytium, which constitutes a network of 
functionally interconnected astrocytes and 
oligodendrocytes. As such, the delayed axonal injury 
may represent a bystander effect of a dysfunctional 
glial syncytium. These observations are intriguing in 
the light of the well-established sensitivity of neurons 
to ischemic injury. Unlike glia, neurons die within 
minutes of ischemia due to Ca2+ overload and caspase 
activation initiated by excessive and uncontrolled 
NMDA receptor activation [49].  
Given the high energy demands placed upon 
myelinated neurons by saltatory conduction, it may 
be surprising that oligodendrocytes should prove 
more vulnerable than their associated axons to 
chronic hypoperfusion injury. Yet oligodendrocytes 
are strictly dependent upon the local supply of 
glucose and oxygen, whereas axons traverse long 
distances, and may be robust to local pockets of 
hypoperfusion, if perfusion is preserved in adjacent 
regions and elsewhere along their path. In addition, 
axons in the adult brain express low levels of NMDA 
and AMPA receptors, while oligodendrocytes express 
moderate amounts of both excitatory receptors [7, 8]; 
axons may thus be relatively tolerant to increases in 
extracellular glutamate. In particular, 
oligodendrocytes are highly sensitive to 
AMPA/kainate receptor activation [7, 50, 51] and 
consequent Ca2+ and Na+ influx, which can 
respectively mediate oligodendrocyte death following 
hypoxia in both young and adult mice [9]. Thus, 
multiple mechanisms may contribute to the relative 
resistance of white matter axons and vulnerability of 
oligodendrocytes following bilateral carotid stenosis. 
We also noted that conditional glial deletion of 
Cx43 under the regulatory control of the GFAP 
promotor, or long-term administrations of MFA, CBX, 
Gap19, or Gap26, all markedly reduced the severity of 
myelin pathology in BCAS mice. Oligodendrocytes 
and astrocytes are extensively coupled by gap 
junctions, forming a functionally intercommunicative 
glial syncytium. Among the various glial gap junction 
connexins, oligodendrocytes largely express Cx29, 
Cx32 and Cx47 [52], whereas astrocytes express Cx30 
and Cx43 [12, 53]. The two cell types are thus coupled 
by heterotypic gap junctions, typically composed of 
either Cx32 docked with Cx30, or Cx47 docked with 
Cx43 [54]. Mice lacking either Cx32 or Cx47 are viable 
through adulthood, although histological 
examination has revealed that they are prone to 
vacuolization in myelin sheaths [31, 55]. In contrast, 
mice with deletion of both Cx32 and Cx47 die at two 
months of age, due to severe myelin pathology [55, 
56]. Similarly, while deletions of either Cx30 or Cx43 
alone have not been reported to affect myelin 
integrity, mice lacking both Cx30 and Cx43 exhibit 
extensive degeneration of myelin and vacuole 
formation [54, 57]. These findings suggest that 
oligodendrocytes depend vitally upon their 
heteromeric gap junction coupling with astrocytes. At 
first glance, it might seem paradoxical then that 
deletion of Cx43 should reduce the severity of white 
matter injury after hypoperfusion. Yet the number of 
functional gap junctions has been reported to fall 
sharply in the setting of cellular stress, as induced by 
ischemia or inflammation, and this decline is 
accompanied by an increased abundance of gap 
junction hemichannels, which connect the cytosol 
directly with the extracellular space [11, 44, 58]. As 
noted above, Cx43 hemichannels exert a key role in 
neuroinflammation, by acting as a conduit for the 
release of glutamate and ATP, which it turn promote 
release of purinergic transmitters and cytokines 
[59-61]. As such, mice with deletion of Cx43 or Cx30 
exhibited less injury, neuroinflammation, and 
neuropathic pain than did wild-type controls in a 
spinal cord injury model [62]. Thus, BCAS may have 
induced less severe injury in Cx43 knockout mice than 
in wild-types because of the contribution of Cx43 
hemichannels (as distinct from functional gap 
junctions) to the propagation of ischemic injury in 
white matter. We tested this hypothesis by 
administering the Cx43 mimetic peptides Gap19 and 
Gap26. In previous publications, Gap 19 blocked Cx43 
hemichannels in a dose-dependent manner, without 
affecting Cx43 gap junction function [26]. Gap26 was 
also suggested to mainly inhibit Cx43 
hemichannels.[59] The protective effect of these two 
peptides against ischemia myelin injury in BCAS mice 
suggests that the Cx43 hemichannels mediate 
deterioration after chronic hypoperfusion injury in 
BCAS mice. In fact, we observed reduced 
microgliosis, as well as astrogliosis in the Cx43 
knockout mice, in which the post-injury extracellular 
glutamate concentrations were lower as well. 
Inflammatory cytokines have been shown to increase 
the calcium-dependent glutamate release in astrocytes, 
and impaired glutamate buffering has been 
implicated in inflammatory conditions such as 
multiple sclerosis [63]. In this regard, Saggu et al. 
reported reduced white matter injury in BCAS mice 
expressing a dominant negative inhibitor of the 
inflammatory signal mediator nuclear factor kappa B 
(NF-kB) when its expression was placed under the 
control of the GFAP promoter [13]. Thus, delayed 
Cx43-mediated enhancement of local inflammation 
might play a novel role in the myelin damage 
observed after BCAS. It is important to note that MFA 
and CBX inhibit gap junctions more than Cx43 [24, 
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25]. To overcome this technical limitation, we also 
tested the protective effects of Cx43 mimetic peptides 
Gap19 and Gap26, as well as the effect of genetic 
deletion of Cx43 specifically in astrocytes. Of note, we 
first determined the minimal effective doses of MFA 
and CBX in initial experiments and then showed that 
prolonged administrations of CBX, MFA, Gap19 and 
Gap26 were without detectable toxicity.  
 Although white matter occupies almost half of 
the volume of the adult human brain [64], few studies 
have focused on the molecular events leading to white 
matter atrophy in vascular dementia, the most 
common type of dementia after Alzheimer’s disease – 
which is itself associated with vascular pathology [3]. 
The relatively sparse capillary density of the white 
matter may represent a contributing factor in the 
selective white matter loss that characterizes the 
chronic hypoperfusion model [9, 65]. Furthermore, 
many of the white matter arterioles are secondary or 
tertiary branches, which are inherently more prone to 
hypoperfusion following proximal occlusion [66]. 
The murine BCAS model utilized in this study 
replicates some of the key features of vascular 
dementia, including white matter pathology and 
cognitive decline, whereas other typically co-morbid 
features, such as the lipohyalinosis and small vessel 
pathology associated with hypertension and diabetes, 
are lacking [67]. Nonetheless, the post-mortem brain 
pathology of vascular dementia patients shares a 
number of features with the anatomic pathology 
noted in our post-BCAS mice, which included both 
reactive micro- and astrogliosis [68], as well as frank 
demyelination. As such, our data suggest that the 
Cx43 gap junctions may comprise a therapeutic target 
in vascular dementia, particularly in those patients 
with risk factors for chronic carotid artery or 
carotid-distribution diseases, such as smoking, 
hyperlipidemia and hypertension. More broadly, the 
relative protection of the post-ischemic central white 
matter by gap junction inhibition suggests the 
interdependency of astrocytes and oligodendrocytes 
in the maintenance and health of forebrain myelin. 
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